Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pharmacological Cardioversion of Atrial Fibrillation”

11 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 11 results

Not applicableStudy completedNCT00215774
What this trial is testing

Flecainide-Short Long Study (Flec-SL)

Who this might be right for
Atrial Fibrillation
Atrial Fibrillation Network 760
Not applicableStudy completedNCT02378155
What this trial is testing

Cerebral Oxygen Saturation Measurement During Cardioversion Because of Atrial Fibrillation

Who this might be right for
Electrical Cardioversion of Atrial FibrillationPharmacological Cardioversion of Atrial Fibrillation
Hasselt University 60
Post-approval studies (Phase 4)Not Yet RecruitingNCT06645249
What this trial is testing

Evaluation of Cardioverter Capacity of Amiodarone Pre-electrical Cardioversion in Persistent Atrial Fibrillation

Who this might be right for
Atrial Fibrillation (AF)
Institut Investigacio Sanitaria Pere Virgili 122
Testing effectiveness (Phase 2)Ended earlyNCT04582409
What this trial is testing

Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of HSY244 in Participants With Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Novartis Pharmaceuticals 13
Not applicableStudy completedNCT00933634
What this trial is testing

Efficacy and Safety of Electrical Versus Pharmacological Cardioversion in Early Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Valduce Hospital 247
Post-approval studies (Phase 4)Study completedNCT03005366
What this trial is testing

Predictive Factors to Effectively Terminate Paroxysmal Atrial Fibrillation by Blocking Atrial Selective Ionic Currents

Who this might be right for
Paroxysmal Atrial Fibrillation
David Filgueiras-Rama 50
Not applicableStudy completedNCT01891058
What this trial is testing

Trial of Electrical Versus Pharmacological Cardioversion for RAFF in the ED

Who this might be right for
Atrial FibrillationAtrial Flutter
Ottawa Hospital Research Institute 396
Post-approval studies (Phase 4)UnknownNCT05720572
What this trial is testing

Antazoline in Comparison to Propafenone in Pharmacological Cardioversion of Atrial Fibrillation.

Who this might be right for
Atrial Fibrillation
Centre of Postgraduate Medical Education 105
Not applicableStudy completedNCT05773170
What this trial is testing

Efficacy and Safety Evaluation of Refralon®, Concentrate for Solution for Intravenous Injection in Patients With Paroxysmal and Persistent Atrial Fibrillation and Flutter

Who this might be right for
Paroxysmal Atrial FibrillationPersistent Atrial FibrillationAtrial Flutter
R-Pharm 1,147
Post-approval studies (Phase 4)UnknownNCT03536806
What this trial is testing

Clinical Efficacy of Potassium Canrenoate in Sinus Rhythm Restoration Among Patients With Atrial Fibrillation.

Who this might be right for
Atrial Fibrillation, Paroxysmal
National Institute of Cardiology, Warsaw, Poland 80
Large-scale testing (Phase 3)WithdrawnNCT03162120
What this trial is testing

Comparison of Effectiveness of Ranolazine Plus Metoprolol Combination vs. FlecainidE pluS Metoprolol Combination in ATrial Fibrillation Recurrences FOllowing PhaRmacological or Electrical CardioverSion of AtRial Fibrillation

Who this might be right for
Atrial FibrillationRecurrence
Elpen Pharmaceutical Co. Inc.